Loading company…
TechnoDerma Medicines develops small-molecule drugs for skin diseases, including atopic dermatitis and hair loss.
Founded in 2014 and based in Chengdu, China, TechnoDerma Medicines Inc., previously known as Tekeluo Biology, researches small-molecule drugs for skin diseases. Its pipeline includes candidates for hair loss, atopic dermatitis, psoriasis and systemic lupus erythematosus. The company completed a Phase 1 dose escalation trial of TDM-180935 for atopic dermatitis in December 2023 and closed a pre-series B round in January 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in